Mediators of Inflammation

Interplay Between Oral Inflammatory Diseases and Impairment of General Health


Publishing date
01 Feb 2023
Status
Closed
Submission deadline
07 Oct 2022

Lead Editor

1University of Belgrade, Belgrade, Serbia

2Academic Centre for Dentistry in Amsterdam, University of Amsterdam and Vrije Universiteit, Amsterdam, Netherlands

3Universidad de Antioquia, Medellín, Colombia

4Nantes Université, Nantes, France

5University of Cagliari, Cagliari, Italy

This issue is now closed for submissions.

Interplay Between Oral Inflammatory Diseases and Impairment of General Health

This issue is now closed for submissions.

Description

Pulpal and periodontal inflammatory diseases are the most common pathologies in everyday clinical dental practice, and epidemiological data indicates a considerable global burden caused by oral inflammatory diseases. These diseases are the consequence of the complex interplay between microbes, their virulence factors, and the immune system of the host.

The local activation of the host’s innate and adaptive immune system is characterized by the recruitment of various cell types and cell-specific mediators, which results in the destruction of tooth supporting tissues. The increase of circulating inflammatory biomarkers may be a consequence of oral infection spreading through the blood system and activation of the systemic immune response, which could lead to the development of generalized low-grade inflammation in the human body and the impairment of the general health of the individual. It is of great interest to investigate the potential pathophysiological mechanisms by which oral inflammatory conditions, through low-grade inflammation, contribute to the development of different general health disorders.

The aim of this Special Issue is to update our current knowledge on the interplay between pulpal and periodontal inflammatory disorders and the impairment of general health based on recent scientific evidence. We hope to attract research presenting novel pathophysiological mechanisms and common paths in oral inflammatory and general health disorders. We especially welcome original research articles analyzing the impact of different inflammatory mediators and low-grade inflammation in associational and longitudinal studies. Explanations of bidirectional relationships between systemic low-grade inflammation and impairment of general health based on strong evidence in animal experimental models are very welcome. We also encourage interventional studies aiming at improving our knowledge on the effectiveness of dental therapy on the level of low-grade inflammation. We welcome both original research and review articles.

Potential topics include but are not limited to the following:

  • Oral inflammatory diseases as a source of low-grade inflammation
  • Inflammatory mediators and low-grade inflammation in different pulpal diseases
  • Inflammatory mediators and low-grade inflammation in different periodontal diseases
  • Low-grade inflammation as a pathophysiological mechanism of general health impairment
  • Association between pulpal/periodontal inflammatory diseases and cardiovascular diseases
  • Association between pulpal/periodontal inflammatory diseases and diabetes mellitus
  • Association between pulpal/periodontal inflammatory diseases and gastrointestinal diseases
  • Association between pulpal/periodontal inflammatory diseases and pregnancy-related disorders
  • Association between pulpal/periodontal inflammatory diseases and autoimmune disorders
  • Association between pulpal/periodontal inflammatory diseases and hematologic disorders
  • Association between pulpal/periodontal inflammatory diseases and cancer
Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.